INTERACTION OF LIPID A AND INNATE IMMUNE RECEPTORS IN NEISSERIA INFECTION
奈瑟菌感染中脂质 A 和先天免疫受体的相互作用
基本信息
- 批准号:8169762
- 负责人:
- 金额:$ 0.18万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-12 至 2011-05-31
- 项目状态:已结题
- 来源:
- 关键词:AcylationClinicalComputer Retrieval of Information on Scientific Projects DatabaseDiseaseEnterobacteriaceaeEpithelial CellsFundingGrantHeterogeneityIL8 geneImmune responseImmunologic ReceptorsInfectionInstitutionInterleukin-6Lipid ALipidsLipopolysaccharidesMyeloid CellsNeisseriaNeisseria gonorrhoeaePathogenesisPatientsPelvic Inflammatory DiseasePhosphorylationPublic HealthResearchResearch PersonnelResourcesSepsisSeveritiesSourceStructureTestingToxic effectUnited States National Institutes of HealthVariantVirulence Factorscytokinelipooligosaccharidemonocyteneutrophilreceptorresponsetoll-like receptor 4
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Infections due to Neisseria gonorrhoeae and N. meningitidis represent a major public health problem around the world. In patients with Neisserial infections, levels of cytokines such as TNF-¿, IL-1¿, IL-6, and IL-8 are greater depending on the severity of the clinical disease presentation. Two innate immune receptors, toll-like receptor 4 (TLR4) and triggering receptor expressed on myeloid cells (TREM), which are expressed on monocytes, neutrophils, and mucosal epithelial cells, are stimulated by lipopolysaccharide (LPS) from enteric bacteria and are required for an efficient immune response. Among the virulence factors involved in the pathogenesis of Neisserial infections, the lipooligosaccharide (LOS) is believed to be a major component inducing host cytokine responses. Several studies have implicated the lipid A (LA) portion as the bioactive component of Neisserial LOS. We hypothesize that heterogeneity in the acylation and phosphorylation of the LA, both of which have been shown to influence the toxicity of LPS from Escherischia coli, underlies the differential reactivity of Neisserial LOS with TLR4 and TREM resulting in differences in cytokines induction during infection. It is apparent that inappropriate innate immune responses to LOS may cause exaggerated responses such as gonococcal pelvic inflammatory disease and meningococcal sepsis. We are testing the postulate that natural variation in LA structure within the LOS of different Neisserial strains is the major determinant of the degree to which cytokines are induced during infection. To this end, we are determining the structure of the LA molecules from Neisserial strains showing variable stimulation of the TLR4 receptor.
该子项目是利用该技术的众多研究子项目之一
资源由 NIH/NCRR 资助的中心拨款提供。子项目和
研究者 (PI) 可能已从 NIH 的另一个来源获得主要资金,
因此可以在其他 CRISP 条目中表示。列出的机构是
对于中心来说,它不一定是研究者的机构。
淋病奈瑟菌和脑膜炎奈瑟菌引起的感染是世界各地的一个重大公共卫生问题。在患有奈瑟氏球菌感染的患者中,根据临床疾病表现的严重程度,细胞因子(例如 TNF-K、IL-1K、IL-6 和 IL-8)的水平较高。 两种先天免疫受体,Toll 样受体 4 (TLR4) 和骨髓细胞表达的触发受体 (TREM),它们表达于单核细胞、中性粒细胞和粘膜上皮细胞,受到肠道细菌脂多糖 (LPS) 的刺激,是有效免疫反应所必需的。 在涉及奈瑟氏球菌感染发病机制的毒力因子中,脂寡糖(LOS)被认为是诱导宿主细胞因子反应的主要成分。多项研究表明脂质 A (LA) 部分是奈瑟氏菌 LOS 的生物活性成分。 我们假设 LA 的酰化和磷酸化的异质性(两者均已被证明会影响大肠杆菌 LPS 的毒性)是奈瑟氏菌 LOS 与 TLR4 和 TREM 的差异反应性的基础,导致感染期间细胞因子诱导的差异。 显然,对 LOS 的不适当的先天免疫反应可能会导致过度反应,例如淋菌性盆腔炎和脑膜炎球菌败血症。 我们正在测试以下假设:不同奈瑟氏菌菌株 LOS 内 LA 结构的自然变异是感染过程中细胞因子诱导程度的主要决定因素。 为此,我们正在确定来自奈瑟氏菌菌株的 LA 分子的结构,这些菌株显示出对 TLR4 受体的不同刺激。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gary A Jarvis其他文献
Gary A Jarvis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gary A Jarvis', 18)}}的其他基金
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10360383 - 财政年份:2021
- 资助金额:
$ 0.18万 - 项目类别:
BLRD Research Career Scientist Award Application
BLRD 研究职业科学家奖申请
- 批准号:
10512756 - 财政年份:2021
- 资助金额:
$ 0.18万 - 项目类别:
Targeting of LOS for Treatment of Antibiotic-Resistant Neisseria gonorrhoeae
LOS 靶向治疗抗生素耐药性淋病奈瑟菌
- 批准号:
10363529 - 财政年份:2011
- 资助金额:
$ 0.18万 - 项目类别:
Targeting of LOS for Treatment of Antibiotic-Resistant Neisseria gonorrhoeae
LOS 靶向治疗抗生素耐药性淋病奈瑟菌
- 批准号:
10617635 - 财政年份:2011
- 资助金额:
$ 0.18万 - 项目类别:
Interaction of LOS and Innate Immunity in Neisseria Infection
奈瑟菌感染中 LOS 与先天免疫的相互作用
- 批准号:
9140859 - 财政年份:2011
- 资助金额:
$ 0.18万 - 项目类别:
INTERACTION OF LIPID A AND INNATE IMMUNE RECEPTORS IN NEISSERIA INFECTION
奈瑟菌感染中脂质 A 和先天免疫受体的相互作用
- 批准号:
7724210 - 财政年份:2008
- 资助金额:
$ 0.18万 - 项目类别:
相似国自然基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
- 批准号:31070748
- 批准年份:2010
- 资助金额:34.0 万元
- 项目类别:面上项目
相似海外基金
Optimal utility-based design of oncology clinical development programmes
基于效用的肿瘤学临床开发项目的优化设计
- 批准号:
2734768 - 财政年份:2026
- 资助金额:
$ 0.18万 - 项目类别:
Studentship
EAGER: Integrating Pathological Image and Biomedical Text Data for Clinical Outcome Prediction
EAGER:整合病理图像和生物医学文本数据进行临床结果预测
- 批准号:
2412195 - 财政年份:2024
- 资助金额:
$ 0.18万 - 项目类别:
Standard Grant
Exploring the Impact of Clinical Diagnosis on Health and Education Outcomes for Children Receiving Special Educational Needs support for Autism
探索临床诊断对接受自闭症特殊教育需求支持的儿童的健康和教育结果的影响
- 批准号:
ES/Z502431/1 - 财政年份:2024
- 资助金额:
$ 0.18万 - 项目类别:
Fellowship
Application of artificial intelligence to predict biologic systemic therapy clinical response, effectiveness and adverse events in psoriasis
应用人工智能预测生物系统治疗银屑病的临床反应、有效性和不良事件
- 批准号:
MR/Y009657/1 - 财政年份:2024
- 资助金额:
$ 0.18万 - 项目类别:
Fellowship
From lymphatics to evaluating resolution therapeutics in clinical trials
从淋巴管到评估临床试验中的解决疗法
- 批准号:
MR/Y013050/1 - 财政年份:2024
- 资助金额:
$ 0.18万 - 项目类别:
Fellowship
Strategy for improving clinical obesity therapeutics
改善临床肥胖治疗的策略
- 批准号:
MR/Y014707/1 - 财政年份:2024
- 资助金额:
$ 0.18万 - 项目类别:
Research Grant
VITAL: VIrtual Twins as tools for personalised clinicAL care
VITAL:虚拟双胞胎作为个性化临床护理的工具
- 批准号:
10106393 - 财政年份:2024
- 资助金额:
$ 0.18万 - 项目类别:
EU-Funded
Quantum-Enabled Brain Imaging: A Pathway to Clinical Utility
量子脑成像:临床应用的途径
- 批准号:
10107115 - 财政年份:2024
- 资助金额:
$ 0.18万 - 项目类别:
Small Business Research Initiative
Determining the clinical utility of BioEP: a multisite, prospective, study
确定 BioEP 的临床效用:一项多中心前瞻性研究
- 批准号:
10090508 - 财政年份:2024
- 资助金额:
$ 0.18万 - 项目类别:
Investment Accelerator
Presymptom: development of a novel machine-learning-derived diagnostic test to rule out infection to enable enhanced clinical care and better targeted anti-microbial use
症状前:开发一种新型的机器学习诊断测试来排除感染,从而加强临床护理和更有针对性的抗菌药物使用
- 批准号:
10089281 - 财政年份:2024
- 资助金额:
$ 0.18万 - 项目类别:
Investment Accelerator














{{item.name}}会员




